KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Short-term Investments (2016 - 2022)

Historic Short-term Investments for Teladoc Health (TDOC) over the last 8 years, with Q2 2022 value amounting to $2.5 million.

  • Teladoc Health's Short-term Investments rose 3.94% to $2.5 million in Q2 2022 from the same period last year, while for Jun 2022 it was $2.5 million, marking a year-over-year increase of 3.94%. This contributed to the annual value of $2.5 million for FY2021, which is 9523.52% down from last year.
  • Latest data reveals that Teladoc Health reported Short-term Investments of $2.5 million as of Q2 2022, which was up 3.94% from $2.5 million recorded in Q1 2022.
  • Teladoc Health's 5-year Short-term Investments high stood at $54.6 million for Q1 2018, and its period low was $2.5 million during Q1 2021.
  • Its 5-year average for Short-term Investments is $18.0 million, with a median of $3.0 million in 2020.
  • As far as peak fluctuations go, Teladoc Health's Short-term Investments soared by 186403.54% in 2020, and later crashed by 9523.52% in 2021.
  • Quarter analysis of 5 years shows Teladoc Health's Short-term Investments stood at $54.5 million in 2018, then tumbled by 95.03% to $2.7 million in 2019, then soared by 1864.04% to $53.2 million in 2020, then crashed by 95.24% to $2.5 million in 2021, then increased by 0.08% to $2.5 million in 2022.
  • Its last three reported values are $2.5 million in Q2 2022, $2.5 million for Q1 2022, and $2.5 million during Q4 2021.